HomeCompareHTSUF vs MO

HTSUF vs MO: Dividend Comparison 2026

HTSUF yields 2.10% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $56.0K in total portfolio value· pulled ahead in Year 5
10 years
HTSUF
HTSUF
● Live price
2.10%
Share price
$29.00
Annual div
$0.61
5Y div CAGR
6.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.1K
Annual income
$469.34
Full HTSUF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — HTSUF vs MO

📍 MO pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTSUFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTSUF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTSUF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTSUF
Annual income on $10K today (after 15% tax)
$178.79/yr
After 10yr DRIP, annual income (after tax)
$398.94/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $25,236.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTSUF + MO for your $10,000?

HTSUF: 50%MO: 50%
100% MO50/50100% HTSUF
Portfolio after 10yr
$52.1K
Annual income
$15,314.25/yr
Blended yield
29.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

HTSUF
No analyst data
Altman Z
4.8
Piotroski
6/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTSUF buys
0
MO buys
0
No recent congressional trades found for HTSUF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTSUFMO
Forward yield2.10%6.36%
Annual dividend / share$0.61$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR6.4%22.6%
Portfolio after 10y$24.1K$80.1K
Annual income after 10y$469.34$30,159.17
Total dividends collected$3.3K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: HTSUF vs MO ($10,000, DRIP)

YearHTSUF PortfolioHTSUF Income/yrMO PortfolioMO Income/yrGap
1$10,924$223.81$10,570$780.30+$354.00HTSUF
2$11,932$243.11$11,381$1,032.90+$551.00HTSUF
3$13,031$264.05$12,535$1,392.73+$496.00HTSUF
4$14,230$286.76$14,193$1,920.91+$37.00HTSUF
5← crossover$15,537$311.39$16,618$2,723.68$1.1KMO
6$16,963$338.09$20,263$3,993.80$3.3KMO
7$18,517$367.05$25,936$6,098.36$7.4KMO
8$20,212$398.44$35,166$9,775.01$15.0KMO
9$22,059$432.46$51,026$16,597.78$29.0KMO
10$24,073$469.34$80,113$30,159.17$56.0KMO

HTSUF vs MO: Complete Analysis 2026

HTSUFStock

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Full HTSUF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this HTSUF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTSUF vs SCHDHTSUF vs JEPIHTSUF vs OHTSUF vs KOHTSUF vs MAINHTSUF vs PMHTSUF vs BTIHTSUF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.